Internal Medicine, Endocrinology, Diabetes, & Metabolism · Colonial Heights, VA
NPI
1023044765
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3660 Boulevard, Suite G
Colonial Heights, VA, 23834
Phone (804) 526-5566
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
2,011 services
Medicare patients, 2024
418
Average age 72
Drug cost, 2024
$2.0M
4,910 prescriptions
Company payments, 2025
$803
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Umadevi Muthyala was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 810 times for 363 patients. In total Umadevi Muthyala billed 2,011 services in 15 codes, and Medicare paid $106K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 810 | 363 | $11.61 | $9,405 |
| 99214 Office E&M - Established | Office | 627 | 340 | $82.62 | $52K |
| 99215 Office E&M - Established | Office | 279 | 165 | $117.59 | $33K |
| 83036 Blood Count | Office | 103 | 82 | $9.37 | $965 |
| 95251 Test - Miscellaneous | Office | 94 | 45 | $22.67 | $2,131 |
| 99204 Office E&M - New | Office | 39 | 39 | $103.12 | $4,022 |
| 99205 Office E&M - New | Office | 18 | 18 | $152.35 | $2,742 |
| 76536 Ultrasound - Nonspecific | Office | 15 | 15 | $68.68 | $1,030 |
By year: 2022 $70K for 822 services; 2023 $86K for 976 services; 2024 $106K for 2,011 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 103 | 82 | $9.37 | $965 |
Medicare prescription drug claims, 2024
In 2024, the drug Umadevi Muthyala prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 285 prescriptions and refills. In total Umadevi Muthyala wrote 4,910 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 285 | 454 | 69 | $435K |
| Metformin Hcl Er Metformin Hcl | 282 | 693 | 80 | $2,789 |
| Levothyroxine Sodium Generic | 278 | 718 | 77 | $2,927 |
| Metformin Hcl Generic | 270 | 724 | 82 | $1,511 |
| Ozempic Semaglutide | 244 | 437 | 60 | $424K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 243 | 542 | 82 | $41K |
| Pioglitazone Hcl Generic | 193 | 447 | 57 | $2,196 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 161 | 377 | 67 | $18K |
| Tresiba Flextouch U-200 Insulin Degludec | 142 | 327 | 39 | $187K |
| Jardiance Empagliflozin | 138 | 240 | 32 | $141K |
| Atorvastatin Calcium Generic | 123 | 330 | 41 | $1,022 |
| Methimazole Generic | 120 | 289 | 36 | $1,300 |
| Humalog Kwikpen U-100 Insulin Lispro | 113 | 212 | 43 | $37K |
| Novolog Flexpen Insulin Aspart | 112 | 233 | 46 | $45K |
| Rosuvastatin Calcium Generic | 101 | 259 | 31 | $828 |
Brand drugs: 2,386 claims; generic drugs: 2,045 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Umadevi Muthyala $803 ($803 in general payments such as food, travel and fees) from 13 companies. The largest payer was Insulet Corporation with $185.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 2 | $185 |
| Lilly USA, LLC LLY | 8 | $142 |
| CeQur Corporation | 1 | $82.26 |
| Dexcom, Inc. DXCM | 4 | $78.53 |
| Amgen Inc. AMGN | 3 | $55.56 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $53.38 |
| Mannkind Corporation MNKD | 2 | $44.23 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $39.33 |
| Abbott Laboratories ABT | 2 | $36.03 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.